Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

IPSEN Income from Continuous Operations 2016-2024 | IPSEY

IPSEN annual/quarterly income from continuous operations history and growth rate from 2016 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • IPSEN income from continuous operations for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • IPSEN income from continuous operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • IPSEN annual income from continuous operations for 2024 was $0.387B, a 42.37% decline from 2023.
  • IPSEN annual income from continuous operations for 2023 was $0.671B, a 7.55% increase from 2022.
  • IPSEN annual income from continuous operations for 2022 was $0.624B, a 18.46% decline from 2021.
  
IPSEN Annual Income from Continuous Operations
(Millions of US $)
2024 $387
2023 $671
2022 $624
2021 $765
2020 $623
2019 $-61
2018 $457
2017 $306
2016 $251
2015 $211
IPSEN Quarterly Income from Continuous Operations
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.218B $3.868B
Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.337B 27.82
Zoetis (ZTS) United States $68.990B 25.03
Daiichi Sankyo, - (DSNKY) Japan $51.110B 26.19
Takeda Pharmaceutical (TAK) Japan $48.365B 9.87
BeOne Medicines - (ONC) Switzerland $34.251B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.677B 0.00
Summit Therapeutics (SMMT) United States $18.831B 0.00
Merck (MKKGY) Germany $16.743B 10.89
Shionogi (SGIOY) Japan $15.067B 15.10
United Therapeutics (UTHR) United States $14.128B 12.23
Neurocrine Biosciences (NBIX) United States $13.172B 39.29
Orion OYJ (ORINY) Finland $11.248B 27.11
Eisai (ESAIY) $9.356B 10.55
Madrigal Pharmaceuticals (MDGL) United States $8.427B 0.00
Corcept Therapeutics (CORT) United States $7.396B 62.12
Grifols, S.A (GRFS) Spain $7.006B 0.00
Stevanato Group S.p.A (STVN) Italy $6.799B 40.09
Ionis Pharmaceuticals (IONS) United States $6.771B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.355B 18.39
Soleno Therapeutics (SLNO) United States $3.551B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.930B 13.93
Crinetics Pharmaceuticals (CRNX) United States $2.772B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.754B 0.00
Hypermarcas (HYPMY) Brazil $2.678B 20.13
Catalyst Pharmaceuticals (CPRX) United States $2.478B 8.30
Centessa Pharmaceuticals (CNTA) United Kingdom $2.322B 0.00
Ocular Therapeutix (OCUL) United States $2.112B 0.00
Dyne Therapeutics (DYN) United States $1.743B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.738B 0.00
Guardian Pharmacy Services (GRDN) United States $1.607B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.584B 23.59
Harrow (HROW) United States $1.415B 0.00
Ardelyx (ARDX) United States $1.412B 0.00
ARS Pharmaceuticals (SPRY) United States $1.363B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.330B 0.00
Evotec AG (EVO) Germany $1.282B 0.00
Xeris Biopharma Holdings (XERS) United States $1.188B 0.00
Collegium Pharmaceutical (COLL) United States $1.185B 6.48
Enliven Therapeutics (ELVN) United States $1.170B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
Akebia Therapeutics (AKBA) United States $0.806B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.698B 7.20
Amylyx Pharmaceuticals (AMLX) United States $0.697B 0.00
ProKidney (PROK) United States $0.682B 0.00
Theravance Biopharma (TBPH) United States $0.677B 56.04
KalVista Pharmaceuticals (KALV) United States $0.640B 0.00
Siga Technologies (SIGA) United States $0.628B 7.76
Elite Pharmaceuticals (ELTP) United States $0.611B 0.00
Bioventus (BVS) United States $0.605B 14.64
Relay Therapeutics (RLAY) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.575B 0.00
Organogenesis (ORGO) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.566B 11.59
Oruka Therapeutics (ORKA) United States $0.545B 0.00
Xencor (XNCR) United States $0.541B 0.00
Savara (SVRA) United States $0.527B 0.00
Nektar Therapeutics (NKTR) United States $0.508B 0.00
Zevra Therapeutics (ZVRA) United States $0.506B 0.00
Nanobiotix S.A (NBTX) France $0.431B 0.00
Esperion Therapeutics (ESPR) United States $0.411B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.335B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.320B 0.00
Altimmune (ALT) United States $0.319B 0.00
4D Molecular Therapeutics (FDMT) United States $0.307B 0.00
Larimar Therapeutics (LRMR) United States $0.302B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 19.32
AleAnna (ANNA) United States $0.268B 0.00
OmniAb (OABI) United States $0.248B 0.00
Galectin Therapeutics (GALT) United States $0.240B 0.00
Lyell Immunopharma (LYEL) United States $0.208B 0.00
Heron Therapeutics (HRTX) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.194B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Korro Bio (KRRO) United States $0.180B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.173B 26.75
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.151B 0.00
Profound Medical (PROF) Canada $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.131B 0.00
Avita Medical (RCEL) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Avalo Therapeutics (AVTX) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 23.81
Liminatus Pharma (LIMN) United States $0.100B 0.00
Surrozen (SRZN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.090B 0.00
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
DURECT (DRRX) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 28.00
FibroGen (FGEN) United States $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.033B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.02
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
PainReform (PRFX) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.19
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.55
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00